Table 3

Summary of pathological findings of prostate specimens in patients with positive nodes in the anterior prostatic fat in comparative series

PatientPreop biopsy histology (Gleason) and imaging for pelvic lymph nodesPreop PSA (ng/mL)Pathological tumour data describedMargin and pelvic lymph node dissection (PLND) statusReference
1
(60 years old)
3+4=7
CT negative
8.87pT3a, 9% involvement of tumour, Gleason 4+3=7Margin negative PLND negative5
2
(70 years old)
3+4=7
(no preop imaging)
7.4pT3a, 36% involvement of tumour, Gleason 3+4=7Margin positive PLND negative5
3
(70 years old)
4+5=9
CT negative
14pT2c, 10% involvement of tumour, Gleason 4+5=9Margin negative PLND negative5
43+3=6
(no data on imaging)
8.610% anterior prostate cancer bilaterally and 90% posteriorMargin negative
PLND negative
6
55+4=9
(no data on imaging)
6.3Multifocal anterior and posteriorMargin positive anteriorly and at bladder neck
PLND negative
6
63+4=7
(no data on imaging)
5.4Multifocal anterior and posteriorMargin positive left apex
PLND not performed
6
74+4=8
(no data on imaging)
8.7Multifocal anterior and posteriorMargin positive posteriorly
PLND positive
6
84+4=8 (no data on imaging)5.0pT3aPLND negative (no data on margin status)7
94+5=9 (no data on imaging)31.5pT3bPLND positive (no data on margin status)7
104+4=8 (no data on imaging)6.1pT3bPLND positive (no data on margin status)7
  • PSA, prostrate specific antigen.